CRB-401: is CAR T-cell therapy the future of multiple myeloma treatment?
Rafael Fonseca • 1 Jun 2018
Early MRD negativity predicts depth of response to CAR T-cells in R/R MM
Nikhil Munshi • 14 Jun 2018
Clinical activity seen with anti-BCMA CAR T-Cell therapy for heavily pre-treated multiple myeloma